Esperion Therapeutics soars amid vague takeover speculation
Source: SeekingAlpha
2025-07-24 13:47:09 ET
More on Esperion Therapeutics
- Can The Promise Of Profitability And Pipelines Sustain A Recovery For Esperion Therapeutics?
- Esperion Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation
- Esperion Therapeutics, Inc. (ESPR) Q1 2025 Earnings Call Transcript
- Esperion settles litigation with Accord Healthcare
- Esperion and HLS partner to commercialize heart disease treatments in Canada
Read the full article on Seeking Alpha
For further details see:
Esperion Therapeutics soars amid vague takeover speculation
Otsuka Corp.
NASDAQ: OSUKF
OSUKF Trading
8196.15% G/L:
$21.57 Last:
300 Volume:
$21.57 Open:
